With the CaptiView image injection module, surgeons see high-resolution data directly in the microscope eyepieces, so that they can remain focused on the patient To make confident decisions during neurosurgery, surgeons often require several different pieces of image data to have a complete picture of the surgical area, for example from IGS systems, fluorescence or... Read more
Washington, DC – March 17, 2017 – GE Healthcare (NYSE: GE), introduced CardioGraphe™, the world’s first dedicated cardiovascular computed tomography (CT) system, at the 66th annual meeting of the American College of Cardiology (ACC). CardioGraphe is the result of a strategic partnership between GE Healthcare and Arineta LTD. The two companies established a relationship in 2010... Read more
As part of its ongoing commitment to provide quality healthcare for Egyptians and accelerating solutions to detect cancer early, GE Healthcare today announced that it has supplied Nile Scan & Labs with its exceptional Positron Emission Tomography/ Computed Tomography (PET/CT) molecular imaging system. The new GE Discovery IQ PET/CT comes with advanced early disease detection... Read more
Download PDF Read more
Technology Collaboration to Power Fabric StandardTM, the Fastest and Most Accurate Secondary Analysis Solution Available March 21, 2017 06:00 AM Pacific Daylight Time OAKLAND, Calif. & MOUNTAIN VIEW, Calif. & PHOENIX–(BUSINESS WIRE)–Fabric Genomics, a global computational genomics company, and Sentieon, which develops highly optimized algorithms for bioinformatics applications, today announced a technology partnership that will enhance... Read more
SCIEX industrialised proteomics solutions, using microflow SWATH® Acquisition, will accelerate cancer research March 21, 2017 Framingham, MA U.S.A. and Sydney, Australia — SCIEX, a global leader in life science analytical technologies, has announced that Children’s Medical Research Institute (CMRI) has opened ProCan™, the Australian Cancer Research Foundation International Centre for the Proteome of Human Cancer.... Read more
New Target Enrichment Product Delivers Deep Coverage of Disease Relevant Content SANTA CLARA, Calif., March 21, 2017 Agilent Technologies Inc. (NYSE: A) today introduced a new target enrichment solution for next-generation DNA sequencing. Agilent SureSelect Clinical Research Exome V2 delivers more than 1,000 additional, disease relevant targets compared to the company’s earlier version of the... Read more
LONDON–(BUSINESS WIRE)–To help address the challenges surrounding supply chain management for cell and gene therapy around the globe, Thermo Fisher Scientific, the world leader in serving science, today announced a collaboration with the Cell and Gene Therapy Catapult (CGT Catapult) to provide developers with both the manufacturing capability and distribution, logistics, and storage capacity needed... Read more
CARLSBAD, Calif. & PHOENIX–(BUSINESS WIRE)–A new high-throughput, microarray-based assay designed to detect more than 6,000 genomic variations associated with inherited disease now provides molecular genetics laboratories with a consolidated and automated, single pan-ethnic solution for expanded carrier status research. Thermo Fisher Scientific announced the CarrierScan™ Assay today at the 2017 ACMG Annual Clinical Genetics Meeting... Read more
New system helps meet increasing demands for larger test volumes and reduces total cost of ownership for hospital laboratories and integrated delivery networks BREA, Calif., March 7, 2017 /PRNewswire/ — Beckman Coulter Diagnostics announces FDA clearance and U.S. commercial launch of its new DxC 700 AU chemistry analyzer. The new system brings together the advanced capabilities... Read more